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ABSTRACT 
 
A growing body of evidence confirms a slow reduction in neonatal deaths, of which the 
majority occur in the early neonatal period. The burden of perinatal deaths is heavy in 
developing countries where the perinatal death rate is about five times higher than its rate 
in developed countries. Similarly, about 99% of maternal deaths occur in developing 
countries. However, to the best of our knowledge, little is known about perinatal outcomes 
of infants born to mothers who die from complications of childbirth. This gap in the existing 
literature motivated us to undertake the study, which aimed to investigate the perinatal 
outcomes of infants born to mothers who died from complications of childbirth at Charlotte 
Maxeke Johannesburg Academic Hospital. It consisted of a retrospective study, over a 10 
year period, on infants weighing  500 g and more or with gestational age of 22 weeks and 
above born to mothers who died from complications of childbirth. A sample size of 122 
mothers and 128 infants eligible were analysed through quantitative methods. Among these 
infants, 85 (66.4%) were born alive. The identified top four obstetrical causes of maternal 
deaths were: non-pregnancy related infections including HIV/AIDS, Hypertensive disorders 
of pregnancy, pre-existing maternal diseases and postpartum haemorrhage. HIV and 
hypertension accounted for more than 50% of maternal deaths. The findings revealed that 
emergency caesarean section was high (70%) and the perinatal survival rate was 55%. 
Maternal parity, Apgar scores at one minute and mode of delivery were identified as the 
main predictors which were statistically associated with perinatal survival, with correlation 
coefficient of + 0.7 (P=0.030), + 0.4 (P=0.000) and + 0.1 (P=0.002) respectively. Concerning 
infants born alive, early neonatal survival rate was 84%. Apgar score at five minutes and 
maternal parity were the sole predictors that were statistically associated with neonatal 
outcomes, with correlation coefficient of +0.3 (P=0.000) and + 0.1 (P=0.019). These findings 
demonstrated that with appropriate labour monitoring, adequate neonatal resuscitation 
and good perinatal care, the majority of those infants would be born alive with four out of 
five surviving to hospital discharge.  
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INTRODUCTION 
 
Despite the global effort in reducing under five mortality rate, perinatal mortality remains a 
major challenge for many Sub-Saharan countries.1 Growing evidence highlights that most 
developing countries have been battling to make significant progress in improving neonatal 
survival rate compared to successful stories of bringing down the under-five mortality rate 
(UFMR). Although occuring only within the first 28 days, neonatal deaths account for about 
43% of all UFMR globally.1  
Almost all neonatal deaths (99%) occur in developing countries2 while they account only for 
52% of total births worldwide.1 Of 3 million neonatal deaths globablly, as estimated in 2011 
by United Nations International Children's Emergency Fund (UNICEF),1 75% occurred  within 
the first week of live (early neonatal death).3-5 Thus  a number of authorities place emphasis 
on an urgent need to focus on strategies to decrease perinatal mortality rate.1, 6 However, 
the difficulties have been, amongest others, poor or lack of records to guide effective 
policies and interventions.1, 6 
As for the maternal mortality rate, it remains a widespred major concern with nearly 
400,000 women dying during childbirth every year.7 On a daily basis, the World Health 
Organization (WHO) estimates  about 800 women die from pregnancy-related 
complications; that is either during pregnancy, at delivery or within 42 days of termination 
of pregnancy.4 Pregnancy–related complications have a significant impact on the fetus and 
result in poor perinatal outcomes.8, 9 
Although significant efforts have been made in last few decades to establish audit and 
feedback on perinatal and maternal deaths,  few countries have reliable prevalance data,  
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particulary on stillbirths and perinatal deaths.10 In addition, the Millennium Development 
Goals did not consider the stillbirths  as an indicator of progress, and as a consequence, 
stillbirths have been continued to be documented inconsistently.11 
As per the recent South African estimates, neonatal deaths represent 34 % of UFMR with a 
stillbirth rate of 20 per 1000 total births and NMR of 15 per 1000 live births.12, 13  Despite a 
high level of deliveries by skilled birth attendants, the figures show that the stillbirths 
reduction rate in South Africa since 1995  has been only 0.7%.14 The perinatal care index 
(PCI) which is a validated measure of quality of care during the perinatal period, is calculated 
as perinatal mortality rate divided by low birth weight rate. PCI  is expected to be below one 
for community health centres and below two for all hospitals. The quality of neonatal care 
in South Africa is considered substandard as there is a high perinatal care index above 2.15 
Indeed, about 44% and 22% of early neonatal deaths are respectively associated with health 
provider and administrative avoidable  factors.16 
The urgency to focus on perinatal mortality globally is explained by  the current alarming 
estimates which highlight that the “failure to improve birth outcomes by 2035 will result in 
an estimated 116 million deaths, 99 million survivors with disability or lost development 
potential, and millions of adults at increased risk of non-communicable diseases”,17 as well 
as the need for effective actions to reduce neonatal mortality rate in sub-Saharan countries. 
Indeed, it is estimated that it will take more than 150 years for the African countries to 
reach the current neonatal survival levels of developed countries  if the current neonatal 
mortality reduction rate remains unchanged.18, 19 
With a ratio of 764 per 100,000 live births, maternal mortality remains high in South Africa, 
with huge disparities ranging from 102 per 100,000 live births in the Western Cape province 
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to 1639 per 100,000 live births in the Eastern Cape.20 It is thought that three conditions, 
namely non-pregnancy-related infections (mainly HIV-related), obstetric haemorrhage, and 
complications of hypertension in pregnancy (pre-eclampsia and eclampsia) are responsible 
for almost two-thirds of potentially avoidable maternal deaths in South Africa.21 
This study aimed to determine the perinatal outcomes of babies born to mothers who died 
from complications related to childbirth.  
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LITERATURE REVIEW 
 
The term “Perinatal mortality” has evolved over time and  is currently defined as the death 
during the first week of life of the foetus after 22 weeks of gestational age or birth  weight 
of 500 g and more, plus the number of stillbirths per 1000 live birth per year.  Stillbirth is 
described as the death of a foetus before delivery, at a gestation age of 22 weeks and 
beyond or weighing 500 g and more.22 It is to be clarified that the previous cut-offs were a 
gestational age of 28 weeks or birth weight of 1000 g. Neonatal mortality, on the other 
hand, is defined as the death of a live-born infant in the first 28 days of life.22  Neonatal 
mortality is divided into early neonatal deaths occurring within the first week of life and late 
neonatal death occurring after 7 days but within 28 days. As previously stated, perinatal 
mortality encompasses both stillbirths and early neonatal deaths.  Thus, the two periods 
(perinatal and neonatal) for mortality assessment overlap in the first week of life. 
It is believed that the perinatal period is the most vulnerable period in the life of an 
individual and the risk of death during this period is higher than at any other period of life.2 
This vulnerability decreases as the infant grows. Indeed, about three-quarters of the total 
neonatal deaths occur within the first week, i.e. early neonatal death and about 45% of 
early neonatal deaths occur within the first 24 hours of life.23 
Globally, recent data estimate that about 4 million stillbirths occur each year, of which over 
40% are intrapartum-related.24-26 
 Studies showed that nearly half of stillbirths were alive at the start of labour and many of 
them may be avoided by simple interventions.27 However, the potentially avoidable factors 
for perinatal mortality have not been considered in the Global Burden of Disease, nor in 
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disability-adjusted life-years lost, and they are not part of the United Nations (UN) 
Millennium Development Goals (MDGs).27, 28  
Like any mortality estimation, the reliability of perinatal mortality estimates depends on the 
completeness with which stillbirths and perinatal deaths are reported.29 It is worth 
mentioning that the stillbirths (a significant proportion of perinatal mortality) are likely to be 
underestimated due to inconsistent definitions and classification systems, as well as poor 
reporting.26, 28, 30, 31 In some developing countries, over 70% of women are still delivering at 
home.32 Evidence shows that the conventional sources of information about births, 
stillbirths, and early childhood deaths often do not exist or are incompletely recorded in 
many developing countries.33-36  
Despite the significant decrease in under-five mortality rates, the neonatal and perinatal 
mortality rates have been decreasing much more slowly, remained static or even increased 
in some parts of the world.37-39 Indeed, the under – five mortality rate has been reduced 
globally from 90 deaths per 1,000 live births in 1990 to 48 per 1,000 live births in 2012.40 On 
the other hand, the contributing proportion of neonatal deaths to under-five mortality rate 
has increased from 37 % in 1990 to 44 % in 2012, and this trend is expected to continue if 
nothing is done to improve the management of labour and neonates requiring special 
care.40 
The perinatal mortality rate (PMR) is a key outcome indicator for new-born care and directly 
reflects prenatal and intrapartum care. PMR has also been proposed as a major determinant 
of maternal health status.4 Another tool to assess the effectiveness of perinatal care is 
perinatal care index (PCI) as described in the introduction. 
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 In the same context, the maternal mortality rate (MMR) is unacceptably high.23 The MMR is 
defined as the annual number of female deaths per 100,000 live births from any cause 
related to or aggravated by pregnancy or its management.23 In 2010, about 287000 women 
died globally during pregnancy and /or following childbirth.  Of these maternal deaths 99% 
occurred in developing countries, with more than half of deaths (56%) occurring in sub-
Saharan Africa, followed by South Asia with 29%. Thus, sub-Saharan Africa and South Asia 
represent 85% of the global maternal mortality burden.41, 42  A woman in a developing 
country is 97 times more likely to die as a result of pregnancy or childbirth complications 
than a woman in a developed country.23 It is also estimated that, at global level, one woman 
dies from complication of pregnancy and / or delivery every two minutes.43 
Millennium Development Goal 5 (MDG 5) has the target of reducing maternal mortality by 
75% and achieving universal access to reproductive health by 2015. Nevertheless, the 
progress in reducing maternal mortality and providing family planning services in developing 
countries has been too slow to meet the targets.44  
In South Africa, scarce and incomplete data on maternal deaths as well as different 
analytical models used have resulted in different  estimates of maternal mortality rates.45 
This MMR is considered to be unacceptbly high.20 Nevertheless, evidence indicates that  
maternal deaths in South Africa have been continuously declining  from around 2004, due to 
the treatement of HIV infected mothers and introduction of the programme of Prevention 
of Mother To Child Transmission (PMTCT).45, 46 This decline was also due to continuous 
efforts to improve the quality of those programmes; including the training of staff, 
counselling and voluntarily HIV testing among pregnant women and early antiretroviral 
(ARV) initiation for pregnant women.47 
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Despite tremendous progress made in HIV treatment in South Africa with the largest 
number of people on antiretraviral therapy in the world,48 HIV and tuberculosis (TB) remain  
an important cause of maternal deaths accounting for 40% and 28% respectively in South 
Africa.45, 46 Other important causes of maternal deaths in South Africa are bleeding 
(haemorrhage) and high blood pressure (hypertension).45, 46 
However, data collected in hospitals indicate that 40% of the causes of maternal deaths are 
preventable in South Africa.46 
The Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), which was the site of this 
study, is a teaching hospital with 1088 beds and offers a full range of health care services 
including highly specialized services.49 The neonatology unit caters for, among others, 
babies with health problems such as very low birth weight infants (weighing < 1500 g).  The 
overall survival rate of very low birth weight infants is 70.5% ranging from 34.9% for 
extremely low birth weight (< 1000 g) to 84.9% for very low birth weight infants 1000-1499 
g.50 On the other hand, the maternal mortality rate (MMR) at the same hospital, was 
estimated at 476 per 100 000 live births in 2008.51 In the context of a referral hospital 
receiving complicated cases, the CMJAH is more likely to have high mortality rates 
compared to national figures. 
The motivation to carry out this research was prompted by the paucity of published studies 
on perinatal outcomes of babies born to mothers who died due to complications of 
pregnancy and / or delivery. In fact, PubMed, Cochrane review databases and other related 
databases include relatively few studies which investigated perinatal outcomes of infants 
born to mothers who died from complications of childbirth. Indeed, the main study found in 
the literature, which looked at perinatal outcomes of infants born to mothers who died 
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from childbirth complications, was the Saleem’s study conducted in seven low and middle-
income countries. In this study, about 70% of stillbirths occurred intrapartum and neonatal 
deaths were 7.4 times higher among women who died, in comparison with those who were 
alive at six week postpartum.52 Consequently, the lack of adequate data impedes effective 
interventions to improve the survival of those infants.10 Therefore, the aim of this study was 
to contribute in filling the gap on the existing knowledge by exploring the perinatal survival 
of infants weighing 500 g and more or of 22 week gestational age and above born to 
mothers who died from childbirth complications  
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OBJECTIVES 
 
Aim 
 
The overall aim of this study was to investigate the perinatal outcomes of infants weighing 
500 g and more or of 22 week gestational age and above born to mothers who died due to 
complications of pregnancy or delivery before being discharged from CMJAH over the 
period of 10 years, starting from the 1st January 2003 up to the 31st December 2012. 
Specific objectives  
 
This study pursued the following objectives: 
1. To describe the demographic and clinical characteristics of infants weighing 500 g and 
more or of 22 week gestational age and above born to mothers who died due to 
complications of pregnancy or delivery in the same period at CMJAH and their mothers’ 
characteristics. 
2. To determine the perinatal survival of infants weighing 500 g and more or of 22 week 
gestational age and above born to mothers who died due to complications of pregnancy 
in the same period at CMJAH. 
3. To identify the factors (both maternal and infant) associated with perinatal survival of 
infants weighing 500 g and more or of 22 week gestational age and above born to 
mothers who died due to complications of pregnancy or delivery in the same period at 
CMJAH. 
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MATERIAL AND METHODS 
 
Design and duration 
 
This was retrospective cohort study of infants born to mothers who died due to 
complications of pregnancy or delivery. Every infant was followed up for the first seven days 
of life except when died or discharged before that time. The study extended over a period 
of 10 years, starting from the 1st January 2003 up to the 31st December 2012. 
Study Population  
 
 Infants born to mothers who died due to complications of pregnancy or delivery at 
CMJAH from 1st January 2003 up to the 31st December 2012.  
 Mothers who died due to complication of pregnancy or delivery at CMJAH from 1st 
January 2003 up to the 31st December 2012. 
Inclusion and exclusion  
 
 Included were:  
o  Infants (either born alive or stillborn) weighing more than 500 g and 
above or with 22 weeks gestational age or more, whose mothers died due 
to complications of pregnancy or delivery before being discharged and 
within 6 weeks post - delivery. 
o Mothers with gestational age of at least 22 week delivered at CMJAH and 
died due to complication of pregnancy or delivery before being 
discharged and within 6 weeks post - delivery. 
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 Excluded were:  
o Infants born before arrival or transferred to CMJAH after delivery. 
o Infants whose records or their mothers were incomplete for analysis. 
o Mothers transferred to CMJAH from other hospitals or clinic after 
delivery. 
 
Data Collection 
 
Data collection sheet checklist (see appendix) 
A data collection sheet of relevant information was developed in Microsoft Word by the 
researcher and was used for coding.  
Sources 
 
To retrieve the information needed, the following sources were used: 
 Perinatal Problem Identification Programme (PPIP) data sheet second version (v2.2) 
form (see appendix) which gives a list of maternal obstetric and final causes of 
maternal deaths; 
 The patients’ files from Medical Record Department, Electronic Medical Record 
Software (MEDICOM) or maternal registers of CMJAH; 
 Compulsory notifications of maternal deaths. 
For infants’ data, the following sources were used: 
 Neonatal/ ICU registers. The department of paediatrics created an electronic 
neonatal database for clinical audit which includes all neonatal admission. 
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 The patients’ files from Medical Record Department, Electronic Medical Record 
Software (MEDICOM) and neonatal registers of CMJAH 
 
Data capturing 
 
The following maternal demographic and clinical characteristics were retrieved from the 
sources mentioned above: age, parity, gravidity, HIV status, antenatal care attendance, 
antenatal steroids, obstetric and final causes of maternal deaths. 
 The following characteristics were captured for infants whose mothers met the criteria for 
inclusion in the study: gestational age, condition at birth (born alive, stillborn, alive on 
admission, fresh stillborn but dead on admission, stillborn and admission status unknown, 
macerated stillborn), mode of delivery, gender, birth weight and outcome at 7 days of age 
(dead or survived).  
The researcher captured all information using Microsoft Excel and when the database was 
completed, it was cleaned and coded before it was imported into analysis package software 
(Stata.11). 
Data cleaning and coding 
 
Data cleaning consisted with double checking the data entry for missing values by the 
researcher to determine internal consistency of this study. Data coding was suggested by 
the researcher and approved by the supervisor. To maintain the patients’ confidentiality, 
the patients were given a research code number. All the codes used appear on the data 
collection sheet. Finally a statistician’s help was obtained for further coding and some of 
inferential analysis. 
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Data analysis 
 
Data in Microsoft Excel sheet were imported to statistical software (STATA version 11) for 
descriptive and inferential analysis on demographic and clinical characteristics of the study 
population. 
Descriptive analysis 
Categorical variables were presented by frequency and percentage. Means and standard 
deviations for numerical variables were also described where appropriate.  
Inferential analysis 
A chi-square test was used to test for association between 2 categorical variables whereas 
the T-test was used to test association between binary categorical variables and numerical 
variables. Probability (P) value of less than 0.05 was regarded as significant. To determine 
association between perinatal outcomes (died or survived) and single individual variable, 
the Binary Outcomes Logistic Regression analysis was used. To determine association 
between perinatal outcomes (died or survived) and more than one variable, Multivariate 
Logistic Regression Model was used. 
Kaplan Meier Survival Curve Estimation which was initially planned in our protocol to be 
used for determining the perinatal survival rate was not used because almost all infants died 
within the first day of life, except one child who died at day 3 of life. 
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RESULTS 
 
A total of 142 mothers meeting the criteria for inclusion in the study were identified.  Of 
these, 20 were excluded because they died before delivery and the details of the foetus 
were not available. This left a total of 122 mothers including six who had twin infants and 
the total of 128 infants who were eligible for analysis.  
INFANTS’ DEMOGRAPHIC AND CLINICAL CHARACTERISTICS 
Gender 
 
Out of 128 infants born to mothers who died before discharge from CMJAH, 14 did not have 
gender recorded. On 114 left, 61% were male and 39% were female.   
Birth weight (g) 
 
 The birth weights of four infants were missing. Out of 124 remaining observations, the 
mean birth weight was 1995.4 g and standard deviation of 867.6 with minimum of 500 g 
and maximum of 3860 g.   The birth weight distribution can be seen in Figure 1. 
Figure 1.Birth weight distribution  
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 Gestational age 
 
Five infants did not have gestational age recorded but their birth weight was more than  
500 g.  Almost three-quarters, 91 out of 123 (74%) were preterm infants. The mean 
gestational age was 32.8 weeks and standard deviation of 4.7 with minimum gestational age 
of 24 weeks and maximum gestational age of 42 weeks. Antepartum steroid information 
was very poorly recorded and available only in 24 cases out of 75 women with gestational  
age < 35. Figure 2 represents the frequency of gestational age distribution. 
 
Figure 2.Gestational age distribution  
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Infant’s conditions at birth 
 
Out of 128 infants born, 85 (66.4%) were born alive.  With regard to 43 stillborn infants, 8 
were bone macerated while 35 infants were fresh stillborn. From fresh stillborn infants, 20 
were assessed alive on the mother’s admission to hospital, 13 were confirmed dead, and 
the status of two foetuses were unknown at the time of maternal admission. The status of 
the infants at birth can be seen in figure 3.  
 
  
Figure 3.Infants' condition at birth 
 
 
 
 
 
 
 
Mode of delivery 
 
 Out of 128 infants, 89 (70%) were born by emergency caesarean. The mode of delivery can 
be seen in Figure 4.  
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Figure 4.Distribution of mode of delivery 
 
 
 
 
Apgar scores for infants born alive 
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scores at five minute was better recorded with 77 out of 85 infants (90.6%) having Apgar 
scores recorded at five minutes. The number of infants with low Apgar scores (≤ 6) at one 
minute decreased at five minutes from 31 to 23 while the number of infants with high Apgar 
1 
2 
2 
34 
89 
0.8% 
1.6% 
1.6% 
26.6% 
69.5% 
0 20 40 60 80 100
Unknown mode of delivery
Assisted vaginal delivery
Elective caesarean section
Normal vaginal delivery
Emergency caesarean section
Percentage and number of children per mode of delivery 
Mode of delivery 
19 
 
scores (7 and above) doubled from one minute to five minute from 25 to 54 respectively. 
Table 1 represents the Apgar scores at one and five minutes. 
Table 1. Apgar scores at one minute  
 
Apgar scores At one minute At fifth minute 
Number Percent Number Percent 
1-3 15 26.8 13 16.9 
4-6 16 28.6 10 13.0 
7 and more 25 44.6 54 70.1 
Total 56 100 77 100 
 
MATERNAL DEMOGRAPHIC AND CLINICAL CHARACTERISTICS 
Maternal age  
 
The minimum maternal age was 15 years and the maximum was 44 years. The majority of 
women were aged between 25 and 34 years. The age distribution of the mothers can be 
seen in figure 5. 
Figure 5. Distribution of maternal age 
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Maternal parity 
 
Two out of 122 women did not have parity recorded in their files. Figure 6 shows the 
distribution of maternal parity of 120 remaining mothers. 
Figure 6. Maternal parity distribution 
 
 
 
 
Antenatal clinic care attendance 
 
The antenatal clinic attendance was recorded for 119 out of 122 women and 76% were 
recorded as having attended the antenatal clinics. However the number of antenatal visits 
was not specified.  
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Maternal HIV status 
 
The HIV status was missing for 21 women, of the 101 remaining women, the HIV prevalence 
was 71%.  
CD4 count  
 
CD4 count was recorded for 61 out of 72 mothers confirmed HIV positive. The minimum 
CD4 count was one and the maximum CD4 count was 789/µL with the median CD4 count of 
29/µL. The figure 7 represents CD4 count distribution per person with nearly three-quarters 
having advanced HIV disease with CD4 count less than 100/µL. 
Figure 7. CD 4 count distribution  
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Obstetric causes of maternal deaths 
 
Out of 122 mothers included in the study, 121 had records on obstetric causes. The top four 
obstetric causes of maternal deaths were non-pregnancy related infections and HIV/AIDS; 
hypertensive disorders of pregnancy; pre-existing maternal diseases and postpartum 
haemorrhage accounting for altogether 82.7%. Table 2 shows the frequency of the obstetric 
causes of maternal deaths.  
 
Table 2. Frequency of obstetric causes of maternal deaths  
 
Obstetric causes of maternal deaths Number Percent 
Non-pregnancy related infections and HIV/AIDS 42 34.7 
Hypertensive disorders of pregnancy 26 21.5 
Pre-existing maternal diseases 18 14.9 
Postpartum haemorrhage 14 11.6 
Other causes:    
             Antepartum haemorrhage 7 5.8 
             No obstetric causes 6 5.0 
             Embolism 3 2.5 
             Acute collapse - causes unknown 2 1.7 
             Pregnancy-related sepsis 1 0.8 
              Anaesthetic complications 1 0.8 
              Unknown 1 0.8 
TOTAL 121 100 
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Final causes of maternal deaths 
 
For the purpose of this study, only one final cause of maternal death, as recorded firstly on 
the PPIP form, was considered because very few mothers had more than one causes. Table 
3 represents the distribution of those causes.  The top four in descending order were, 
namely, respiratory failure including TB, cardiac failure, hypovolemic shock and Immune 
system failure with HIV/AIDS representing together more than 70% of all final causes of 
maternal deaths. 
Table 3.Final causes of maternal deaths  
 
Final cause of Maternal Deaths Number Percent 
Respiratory failure 26 21.2 
Cardiac failure 26 21.2 
Hypovolemic shock 23 18.9 
HIV / AIDS 13 10.8 
Other causes:   
Liver failure 9 7.3 
Cerebral complications 9 7.3 
Septic shock 3 2.4 
Renal failure 3 2.4 
Disseminated intravascular coagulation 3 2.4 
Multi-organ failure 1 0.8 
Metabolic 1 0.8 
Unknown & other 6 4.8 
TOTAL 123  100.0 
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PERINATAL OUTCOMES 
 
For the purpose of this study, the term “perinatal outcomes” was used for all infants (born 
alive and stillborn), while the term “early neonatal outcomes” was considered only for 
infants born alive and observed for the first week of live. 
Perinatal outcomes 
 
A total of 128 infants records were reviewed for analysis, of whom five were excluded:  four 
infants born alive but did not have their outcomes recorded in their files (dead or survived) 
and another infant who was stillborn had no record about other variables (weight, gender, 
Apgar’s, etc.).   Of the remaining 123 infants, 42 (34%) were stillbirths, 13 (11%) died and 68 
(55%) infants survived to 7 day of life. The perinatal outcomes can be seen in figure 8. 
Figure 8. Perinatal outcomes  
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Early neonatal outcomes  
 
Out of 85 infants born alive (Table 4), the outcomes of four infants were not available in the 
records.  Of the remaining 81 infants, the majority (83.9%) infants survived to 7 day of life or 
were discharged before 7 days of age. Figure 9 represents early neonatal outcomes of 
infants born alive.   
Figure 9.Early neonatal outcomes  
 
 
 
 
Characteristics of infants born alive and then subsequently died  
 
Details of the 13 infants who were born alive and then subsequently died are listed in table 
4. All of them had poor Apgar scores at five minute (≤ 5); and it can be seen that all of the 
deaths were attributed to perinatal asphyxia. However, all of them, except one, were 
premature infants with gestational age of 35 weeks or less; thus hyaline membrane disease 
might have been an underling factor in some of these deaths. 
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Table 4.Birth weight, gestational age (GA), Gender, Apgar scores at five minute and 
presumed causes of death of infants born alive 
 
Number Weight(g) G.A. Gender 5 min. Apgar scores Presumed cause of death 
1 680 26 Female 2 Perinatal asphyxia  
2 695 24 Male 1 Perinatal asphyxia  
3 780 28 Male Missing Perinatal asphyxia  
4 1003 33 Male 1 Perinatal asphyxia 
5 1010 28 Male . Perinatal asphyxia 
6 1100 33 Male 3 Perinatal asphyxia 
7 1180 31 Male 2 Perinatal asphyxia 
8 1700 31 Male 3 Perinatal asphyxia 
9 1900 Missing Female 0 Perinatal asphyxia 
10 2130 34 Female 4 Perinatal asphyxia 
11 2180 34 Male 5 Hypoxic Ischemic 
Encephalopathy 
12 2910 35 Male 0 Perinatal asphyxia 
13 3000 38 Male 2 Perinatal asphyxia 
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ASSOCIATION WITH INFANTS’ OUTCOMES 
 
With regard to factors associated with perinatal outcomes of infants born to mothers who 
died as complications of childbirth, all infants (still births and born alive) were initially 
considered together. Then, infants born alive were appraised alone to determine the factors 
associated with early neonatal outcomes. Analysis commenced with univariate binary 
outcomes logistic regression to look at individual variable association with outcomes (either 
survived or died) followed by multivariate logistic regression to examine more than one 
variables and to determine which one(s) predict (s) perinatal or early neonatal outcomes.  
There were 11 variables which were the most recorded and those variables which were 
selected for analysis. Those variables were namely; Apgar scores, birth weight, gestation 
age, gender, mode of delivery, maternal age, maternal parity, maternal HIV status, ANC 
attendance, obstetrical and final causes of maternal deaths.  
For the purpose of analysis some variables were organised in groups. Apgar scores was 
classified into four groups of 0; 1-3; 4-6 and 7 and above. Birth weight was categorised into 
four groups of less than 1000 g; 1000 - 1499 g; 1500 - 2499 g and 2500 g and more. 
Gestational age was divided into four groups of less than 28 weeks; 28 - 32 weeks; 33 - 36 
weeks and 37 weeks and more. Maternal age was stratified into four groups of less than 18 
years; 18-25 years, 26-35 years and 36 years and above.  Obstetric as well as final cause of 
maternal deaths were analysed as they are grouped on PPIP data sheet 2nd version (PPIP 
v2.03) (Appendix). 
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Factors associated with perinatal outcomes 
 
Univariate binary logistic regression analysis 
 
All 11 variables were analysed individually to look for association between each and 
perinatal outcomes. Apgar scores at one minute were considered for all babies including 
stillbirths in our analysis. The P value of less than 0.05 was considered statistically 
significant. Apgar scores at one minute, birth weight and gestational age were infant factors 
which were found to be statistically significant associated with perinatal outcomes. While 
maternal parity was the only maternal factor which was found to be statistically associated 
with perinatal outcomes. For each selected variable, number of observations, odds ratio 
(O.R), P value and 95% CI are represented in table 5 which shows association between 
perinatal outcomes and those variables. The factors found to be associated with perinatal 
outcomes were, Apgar scores at one minute, birth weight gestational age and maternal 
parity.    
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Table 5.Association between perinatal survival and selected variables  
 
Variables Number of 
observations 
O.R P value 95% C.I 
Apgar scores  at 1 minute 98 62.2 0.000  8.172  –73.804  
Birth Weight 120 2.3 0.000 0.007 – 0.109 
Gestational Age 120 1.9 0001 1.274 – 2.764 
Maternal Parity 122 1.5 0.019 1.069 – 2.2116 
Mode of delivery (caesarean section) 123 1.2 0.123 0.957 – 1.440 
GENDER  112 1.5 0.332 0.675 – 3.198 
ANC Attendance 124 1.0 0.811 0.982 – 1.014 
Maternal Age  124 1.0 0.752 0.528 – 1.587 
HIV Status 76 1.0 0.483 0.994 – 1.013 
Obstetrical Causes of Maternal Deaths 117 1.0 0.896 0.865 – 1.134 
Final Causes of Maternal Deaths 122 1.0 0.467 0.807 – 1.067 
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Multivariate logistic regression analysis 
 
74 infants had records of all 11 variables. Multivariate logistic regression model was used to 
look for predictor(s) of overall perinatal outcomes. The P value of less than 0.05 was 
considered statistically significant. A strong positive association was fund between maternal 
parity and perinatal survival rate with correlation coefficient of + 0.7 (P=0.03, 95% CI -0.007 
– 0.130). Apgar scores at one minute had moderate positive association with perinatal 
survival rate, correlation coefficient of + 0.4 (P=0.000, 95% CI 0.309 – 0.406). Previous 
association found between perinatal outcomes and birth weight as well as gestational age 
as shown in table 5 could not be found. In addition, although weak association, mode of 
delivery became positively associated with perinatal outcomes, with correlation coefficient 
of + 0.1 (P=0.002, 95% CI 0.022 – 0.090);  on the other hand caesarean section was found to 
be a protective factor for perinatal survival in multivariate analysis. While ANC attendance 
showed extremely very weak positive correlation with perinatal survival rate; the coefficient 
of correlation was very close to zero (+ 0.0024) as shown in table 6.  
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Table 6.Association between perinatal outcomes and selected variables by multivariate 
analysis 
 
Overall perinatal outcomes Coefficient P value 95% C.I 
Maternal Parity + 0.7 0.030 0.007 – 0.131 
Apgar scores  at 1 minute + 0.4 0.000 0.307 – 0.406 
Mode of delivery (caesarean section) + 0.1 0.002 0.022 – 0.090 
ANC Attendance + 0.0 0.032 0.000 – 0.005 
Birth Weight + 0.1 0.773 - 0.080 – 0.107 
Gestational Age - 0.4 0.326 - 0.128 – 0.043 
Gender  + 0.0 0.438 - 0.071 – 0.161 
Maternal Age  - 0.4 0.533 - 0.132 – 0.069 
HIV Status - 0.0 0.262 - 0.002 – 0.001 
Obstetrical Causes of Maternal Deaths +0.1 0.410 - 0.013 – 0.032 
Final Causes of Maternal Deaths - 0.0 0.242 - 0.001 – 0.000 
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Factors associated with early neonatal outcomes 
 
Univariate binary logistic regression analysis 
 
The same 11 variables were considered and the same variables’ categories, as described 
before, were maintained where applicable. Each variable was individually analysed together 
with early neonatal outcome to establish association between them. The P value of less 
than 0.05 was considered statistically significant.  
Apgar scores at five minutes was used, as it was the most often recorded, and there was 
also a strong correlation between Apgar scores at one minute, at five and at ten minute as 
showed by the following table: 
Table 7.Correlation of Apgar’s scores at different times  
 
Apgar scores Power of correlation of Apgar scores 
Apgar score at one 
min 
Apgar score at five 
min 
Apgar score at ten 
min 
Apgar score at one 
minute 
1.00   
Apgar score at five 
minute 
0.97 1.00  
Apgar score at ten 
minute 
0.94 0.98 1.00 
 
 
 
The variables found to be statistically significant associated with early neonatal survival rate 
in univariate analysis, were Apgar scores at five minute, birth weight and maternal parity. 
The following table shows association between early neonatal survival and selected 
variables. 
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Table 8.Association between early neonatal outcomes and selected variables 
 
Variables Number of 
observations 
O.R P value 95% C.I 
Apgar scores  at 5 minute 75 18.0 0.000  4.278  –76.439  
Birth Weight 81 2.5 0.010 1.243– 4.945 
Maternal Parity 79 3.1 0.007 1.365– 6.814 
Gestational Age 79 1.5 0.201 0.658–  10.372 
Mode of delivery (caesarean section) 81 1.2 0.295 0. 858 – 1.651 
Gender  79 1.5 0.332 0.675 – 3.198 
ANC Attendance 77 0.5 0.230 0. 127 – 1.642 
Maternal Age  81 0.7 0.422 0. 275 – 1.716 
HIV Status 62 0.9 0.850 0. 192 – 3.895 
Obstetrical Causes of Maternal Deaths 76 0.9 0.583 0. 774 – 1.155 
Final Causes of Maternal Deaths 80 0.9 0.344 0.729 – 1.116 
 
Multivariate logistic regression analysis 
 
All 11 variables were recorded for 67 infants whose records we analysed using multivariate 
logistic regression model for all variables to look for predictor(s) of perinatal outcomes. A P 
value of less than 0.05 was considered statistically significant. Apgar scores at five minutes 
had a moderately positive association with early neonatal outcome, correlation coefficient 
of + 0.3 (P=0.000, 95% CI 0.212 – 0.404). While maternal parity showed a weak positive 
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association with early neonatal survival, correlation coefficient of + 0.1 (P=0.019, 95% CI 
0.015 – 0.161). Table 9 shows association between perinatal outcomes and different 
variables. 
Table 9.Association between early neonatal survival outcomes and selected variables by 
multivariate analysis 
 
Perinatal survival Coefficient P value 95% C.I 
Apgar scores  at five minute + 0.3 0.000 0.212 – 0.404 
Maternal Parity + 0.1 0.019 0.015 – 0.161 
Mode of delivery (caesarean section) + 0.0 0.596 - 0.031 – 0.053 
Birth Weight + 0.0 0.802 - 0.109 – 0.140 
Gestational Age - 0.0 0.564 - 0.131 – 0.072 
Gender  + 0.0 0.690 - 0.111 – 0.167 
Maternal age  - 0.1 0.430 - 0.173 – 0.075 
HIV Status + 0.0 0.948 - 0.002 – 0.002 
ANC Attendance + 0.0 0.127 - 0.001 – 0.005 
Obstetrical causes of maternal deaths + 0.0 0.677 - 0.000 – 0.001 
Final causes of maternal death - 0.0 0.952 - 0.025 – 0.023 
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DISCUSSION  
 
The goal of this study was primarily to investigate the perinatal outcomes of infants 
weighing more than 500 g and more whose mothers died due to complications of pregnancy 
and /or delivery within 42 days before being discharged from CMJAH. Secondarily, it aimed 
to determine the factors associated with perinatal outcomes of those infants. Lastly it 
sought to contribute to the body of the existing knowledge in this area of perinatology.  
Over a period of ten years, from January 2003 to December 2012, a total of 128 infants with 
birth weight of 500 g or more born to 122 mothers who died from complication of childbirth 
after 22 weeks of gestational age were reviewed. Although this study was conducted at one 
site, our sample size is about one third of the sample studied by Saleem et al. with 345 
neonates born to 336 women who died during childbearing and their sample was selected 
from seven countries in middle and low-income countries.52  
The results showed that  the majority of infants, i.e. 85 out of 128 infants (66.4%) who were 
born to mothers who died from childbirth complications, were born alive (table 4) whereas 
43 out of 128 infants born to mothers who died due to childbirth complications (33.6%) 
were stillborn. This stillbirths rate is comparable to the one found in the Saleem study 
where 110 out of 145 infants, i.e. (31.8%) born to mothers who died during childbearing 
were stillborn.52 However, the number of stillbirths occurring during labour and/or delivery 
was higher in the Saleem study (66%) than its number found in our study (46%). The lower 
rate of stillbirths which occurred during labour and/or delivery in our study, perhaps reflects 
better labour monitoring and prompt decision, such as emergency caesarean section, to 
save the babies at CMJAH in comparison with other hospitals in low and middle-income 
countries.  Indeed, emergency caesarean sections were done to save the lives of infants in 
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70% of instances. This rate of caesarean sections is very high compared to the general 
estimates in sub-Saharan countries,53, 54  as well as from the global estimates of emergency 
caesarean sections which is 15%.53-56 These results should be interpreted within the context 
of teaching hospital like CMJAH, which is usually more equipped with more qualified staff 
and necessary resources than many other health facilities in low and middle-income 
countries. The rate of emergency caesarean sections performed on the mothers who died 
from childbearing in our study was found to be higher than the usual rate which is 50% at 
CMJAH.57 This high rate of emergency caesarean sections should be understood as an 
indication to promptly save the babies in this particular group of mothers who were 
severely sick and dying. Being statistically significant associated with perinatal survival in 
multivariate analysis, caesarean section was found to reduce intrapartum-related stillbirths. 
This protective effect from caesarean section was found in other studies such as 
Darmstadt’s study,58 especially when the maternal and/or foetal lives were threatened. 
A significant number of stillbirths (30%) were confirmed dead prior to admission in our 
study, and this is similar to results from studies conducted at teaching hospital level for all 
stillbirths.59-61 This may be explained by delay consultation/referral to teaching hospitals or 
by maternal risk factors such as hypertension and placenta abruption, to name few, as 
suggested by other studies.62, 63 
As observed by some studies,3, 11, 52 our study found that most of neonatal deaths occurred 
within the first 24 hours.   
In regard with the survival rate, our study revealed that early neonatal survival rate was 85% 
for infant born alive. These findings were almost double of the survival rate found by Saleem 
et al. study, which was 45%, i.e. 154 out of 345 survived. This high perinatal survival rate 
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could be explained by the level of both obstetric and perinatal care at CMJAH. The level of 
advanced care could be attributed to trained staff and adequate life support resources 
usually available at teaching hospitals in comparison with other health facilities in middle 
and low-income countries in general. 
Concerning the causes of perinatal deaths, perinatal asphyxia was found to be the main 
cause. Indeed, all 13 infants who died had low (≤ 5) Apgar scores at five minute (Table 4). 
However, hyaline membrane disease was also presumed to be an underlying factor in many 
of those deaths as nearly 70% of those infants were less than 34 weeks of gestational age. 
These findings are in keeping with the study of Pattinson et al which found that asphyxia 
and prematurity are the most common causes of perinatal deaths in South Africa.64, 65  
These results are also in agreement with other various studies done in different settings.28, 
66-69 
As for factors associated with perinatal outcomes, birth weight and gestational age were 
statistically associated with perinatal survival, with P value of 0.000 and 0.003 respectively, 
in univariate binary logistic regression analysis.  However, this association could not be 
found in multivariate logistic regression analysis. Using multivariate analysis, the overall 
predictors of perinatal outcomes of all infants born to mothers who died from childbirth 
complications were maternal parity, Apgar scores and mode of delivery.  Thus the condition 
of the fetus/neonate at birth would appear to be more important than the weight or 
gestation as a predictor of survival.  The association between mode of delivery association 
and perinatal survival suggests that caesarean section may have been life saving for the 
baby in some instances.  
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With regards to infants born alive only, Apgar scores at five minute, birth weight and 
maternal parity were the sole predictors that were statistically associated with early 
neonatal outcomes.  Even though prematurity was presumed to be an underlying cause in 
some perinatal deaths as discussed above, perinatal asphyxia as for the case when both 
stillbirths and live births were analysed, was ascertained to be the main cause of all 
perinatal deaths as all infants born alive and then subsequently died had extremely low 
Apgar’s scores. The number of infants with low Apgar scores (≤ 3) decreased from 27% at 
one minute to 17% at five minutes; while the number with high Apgar scores (7 and above) 
increased from 45% at one minute to 70% at five minute. This reflects successful neonatal 
resuscitation at CMJAH in the case a number of babies. In multivariate analysis, the 
association between early neonatal outcomes and birth weight could not be found due to 
the reason given above (analysis in the presence of powerful determinants). Apgar score 
and maternal parity were found to be the sole predictors which were statistically significant 
associated with early neonatal outcomes in multivariate analysis. 
With respect to causes of maternal death, our results were in agreement with those found 
in other studies conducted in developing countries, with HIV, hypertension and antepartum 
haemorrhage being the top causes of obstetrical causes of maternal deaths.70, 71 Concerning 
HIV/AIDS, although HIV prevalence was 71%, only 24 % of HIV positive mothers were on 
antiretroviral therapy and about three-quarters were at an advanced stage with CD4 < 
100/µL. These results should be interpreted within the context that antiretroviral therapy 
for pregnant women was introduced more recently and thus many mothers had advanced 
HIV/AIDS in our study. 
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For the purpose of this study, a focus was made on perinatal outcomes (within the first days 
of live) of infants born to mothers who died from childbearing complications. It was beyond 
the scope of the current research to make a long-term follow up of these infants to 
investigate their outcomes at one year corrected age. Similarly, a longer period follow up 
would have been important to report on their social and psychological aspects. 
 
 
 
 
LIMITATIONS. 
 
This study had to face two main limitations: 
 
1. Poor keeping of medical records:  
There was generally poor record keeping where some patients’ files 
were unavailable either in archives or on electronic database. 
 
2. Missing data:  
Even within the patients’ files which were found, there were many 
missing data.  
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CONCLUSION 
 
This study attempted to address the issue of perinatal outcomes of infants born to mothers 
who died due to childbirth complications at CMJAH between January 2003 and December 
2013. Despite a lot of supporting literature which shows that mothers’ complications from 
childbearing put the foetus at great risks including stillbirths and/or early neonatal death, 
little is known about perinatal outcomes of infants born to mothers who die from childbirth 
complications. It was a retrospective study which focused on infants weighing 500 g and 
above or with 22 weeks and more of gestational age born to mothers who died before being 
discharged from CMJAH. Our sample size was 128 infants born to 122 mothers who died as 
a result of childbirth complications. 
 The results from this study showed that the majority (66.4%) of infants born to mothers 
who died were born alive. There was a significant proportion of stillbirths (30%) occurring 
before admission to the hospital. However, the rate of stillbirths occurring around delivery 
at CMJAH was lower (46%) compared to its rate in middle and low-income countries (66%). 
The majority of infants (70%) were born by emergency caesarean. The identified main cause 
of perinatal mortality was perinatal asphyxia, which reflects the magnitude of foetal insult 
during labour or delivery of infants born to mothers who died due to childbirth 
complications. The perinatal survival rate was 55% while early neonatal survival rate was 
84%. The main predictors which were statistically associated with perinatal outcomes were, 
maternal parity, Apgar scores at one minute and mode of delivery in multivariate analysis. 
Apgar scores at five minutes and maternal parity were found to be the sole predictors 
associated with early neonatal outcomes. 
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RECOMMENDATIONS 
 
1. For hospitals, it is recommended that: 
 An effort to improve the quality of recording stillbirths and early neonatal 
deaths data should be made by all health workers and clerks in labour ward, 
caesarean section theatre and the neonatology unit at CMJAH.  
 A system to link perinatal deaths and maternal deaths should be initiated by 
the CMJAH administration, so that specific conclusions could easily be drawn 
to guide specific interventions to improve both maternal and perinatal 
survival. 
2. For investigators/ researchers, it recommended that: 
 More research studies be undertaken by different researchers to provide 
enough data for guiding decision making in selecting most cost-effective, 
context sensitive and appropriate interventions to reduce both maternal and 
perinatal deaths. 
 Studies be conducted by researchers to determine feasibility and 
effectiveness of linking maternal deaths and perinatal deaths databases. 
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Data Collection Sheet & Coding 
 
A. INFANT DATA: 
1. INFANT CODE : REMOVE GT, THEN YEAR + PSI (PERINATAL 
SURVIVAL)+ 6 LAST DIGIT, FOR TWIN T1 AND T2 WILL BE ADDED 
2. MATERNAL CODE: REMOVE GT, THEN YEAR + PSM (PERINATAL 
SURVIVAL)+ 6 LAST DIGIT 
3. DATE OF BIRTH: 
4. CONDITION AT BIRTH: ( Please tick appropriate answer) 
a. Born alive= 1 
b. Stillborn, alive on admission to hospital =2 
c. Fresh stillborn, dead on admission to hospital =3 
d. Stillborn, admission status unknown =4 
e. Macerated stillborn =5 
5. MODE OF DELIVERY: ( Please tick appropriate answer) 
a. Normal vaginal delivery =1 
b. Vaginal breech =2 
c. Assisted vaginal delivery =3 
d. Elective CS =4 
e. Emergency CS =5 
6. BIRTH WEIGHT: …. g;  or a dot if unavailable;  SEX: male= 1/ 
female=2/intersex =0 ( Please tick appropriate answer) 
7. APGARS: 1ST MIN:             5TH MIN                  10TH MIN: (exact number 
or a dot if unknown) 
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8. RESUSCITED: ( Please tick appropriate answer) 
a. No=0 
b. Oxygen=1 
c. Bagged=2 
d. Chest compression=3 
e. Adrenaline =4 
f. Intubated =5 
g. Unknown = 99 
 
9. OUTCOME AT 7 DAYS: ALIVE =1 / DEAD = 0 or. (dot) for unknown 
a. IF DEAD THE SAME DAY AND ADMITTED TO TU AFTER 
RESUSCITATION INDICATE NUMBER OF HOURS 
10. DATE OF OUTCOME WITHIN 7 DAYS 
B. MATERNAL DATA  
1. IDENTIFICATION CODE : REMOVE GT, THEN YEAR + PSM 
(PERINATAL SURVIVAL)+ 6 LAST DIGIT 
2. DATE OF ADMISSION: 
3. DATE OF DELIVERY: 
4. DATE OF DEATH: 
5. PRIMARY OBSETRIC CAUSE(S) OF DEATH: USE THE CODES IN PPIP 
6. CONTRIBUTORY FINAL CAUSE (S) OF DEATH: USE THE CODES IN 
PPIP 
7. MATERNAL AGE: (please circle)        …..      yr        UNKNOWN  (0) 
8. ANTENATAL CARE: (please circle)   YES (1)         NO (2)      
UNKNWON(99)             
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9. SYPHILIS SEROLOGY:  (please circle)   POSITIVE(1)    NEGATIVE (2)     
UNKNOWN/ UNBOOKED(99) 
10. HIV SEROLOGY: POSITIVE (1) : (please circle)  NEGATIVE(2)     
UNKNOWN/ UNBOOKED(99) 
a. IF HIV POSITIVE : 
 RECEIVED ART:  (please circle) YES (1)         NO (2) 
NOT APPLICATBLE (3) 
UNKNOWN FOR HIV POSITIVE 
(.) AND (99) IF UNBOOKED 
11. CD4   
a. KNOWN : EXACT NUMBER 
b. UNKWON: (ONE DOT) 
c. NOT APLICABLE FOR HIV NEGATIVE MATHERS: (TWO 
DOTS) 
d. NOT AVAILABL: AUSE MOTHER UNBOOKED: (THREE DOTS) 
12. TB 
a. ACTIVE TB ON TREATMENT (1) 
b. NO HISTORY OF TB (2) 
 
c. SUSPECTED TB NOT ON TREATMENT (3) 
d. UNKNOWN TB STATUS (.) FOR HIV POSITIVE, AND (99) IN 
OTHER CASES (HIVE NEGATIVE AND UNBOOKED 
MOTHERS) 
13. GESTATION (WEEK): 
a. EXACT WEEKS OR (DOT) IF UNKWON 
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b. IF GESTATION LESS THAN 35 WEEKS:  
RECEIVED STEROIDS: (please circle)    YES (1)    NO (2)  
NOT APPLICABLE (3)   UNKNWON (99)       
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Codes & Description of Obstetric Cause of Maternal Death (version: 2.03) 
 
Code Description 
0100 NO OBSTETRIC CAUSE 
0110 Unspecified obstetric causes of death 
0120 Assault 
0130 Trauma 
0140 Suicide 
0150 Herbal medicine 
0160 Other 
0200 PRE-EXISTING MATERNAL DISEASE 
0211 Undiagnosed cardiac disease 
0212 Mixed mitral valve disease 
0213 Other rheumatic heart disease 
0214 Artificial valve complications 
0215 Congenital heart disease 
0216 Arrhythmias 
0217 Cardiomyopathy 
0218 Other cardiac disease 
0221 Diabetes mellitus 
0222 Thyroid disease 
0223 Other endocrine disease 
0231 Liver disease 
0232 Intestinal disease 
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0233 Pancreatitis 
0234 Other gastrointestinal disease 
0241 Cerebrovascular accident 
0242 Epilepsy 
0243 Other central nervous system disease 
0250 Respiratory disease 
0260 Haematological disease 
0271 Renal disease 
0272 Genital disease 
0281 Collagen disease 
0282 Other immune disease 
0291 Kyphoscolyosis 
0292 Dwarfism 
0293 Other skeletal disease 
0300 NON-PREGNANCY RELATED INFECTIONS AND AIDS 
0310 Pneumonia 
0320 Acquired Immune Deficiency Syndrome (AIDS) 
0330 Tuberculosis 
0340 Bacterial endocarditis 
0350 Pyelonephritis, urinary tract infection 
0360 Appendicitis 
0370 Malaria 
0380 Meningitis 
0390 Other 
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0400 ECTOPIC PREGNANCY 
0410 Ectopic pregnancy less than 20 weeks 
0420 Extra-uterine pregnancy (more than 20 weeks) 
0500 ABORTION 
0510 Septic abortion 
0520 Uterine trauma 
0530 Trophoblastic disease 
0600 PREGNANCY-RELATED SEPSIS 
0610 Amniotic fluid infection with ruptured membranes 
0620 Amniotic fluid infection with intact membranes 
0630 Puerperal sepsis following normal delivery 
0640 Puerperal sepsis following caesarean section 
0650 Sepsis after normal delivery with obstructed labour present 
0660 Sepsis after caesarean section with obstructed labour 
0670 Other pregnancy-related sepsis 
0700 ANTEPARTUM HAEMORRHAGE 
0710 Abruptio placentae 
0720 Abruptio placentae with hypertension 
0730 Placenta praevia 
0740 Other antepartum haemorrhage 
0800 POSTPARTUM HAEMORRHAGE 
0810 Retained placenta; placenta accreta, increta, percreta 
0820 Uterine atony due to uterine over distention 
 
58 
 
 
Code & Description of Final Cause of Maternal Death (version: 2.03) 
 
Code Description 
0100 HYPOVOLAEMIC SHOCK 
0110 Hypovolemic shock following postpartum haemorrhage 
0120 Hypovolemic shock following antepartum haemorrhage 
0130 Hypovolemic shock following ectopic pregnancy 
0200 SEPTIC SHOCK 
0210 Septic shock following an abortion 
0220 Septic shock following a viable pregnancy 
0230 Septic shock following an incidental infection 
0300 RESPIRATORY FAILURE 
0310 Adult respiratory distress syndrome 
0320 Pneumonia (including Tuberculosis) 
0330 Acute respiratory failure 
0400 CARDIAC FAILURE 
0410 Pulmonary oedema 
0420 Cardiac arrest 
0500 RENAL FAILURE 
0510 Acute tubular necrosis 
0520 Acute medullary necrosis 
0600 LIVER FAILURE 
0610 Liver failure following HELLP syndrome 
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0620 Liver failure following drug overdose 
0700 CEREBRAL COMPLICATIONS 
0710 Intracerebral haemorrhage 
0720 Cerebral oedema resulting in coning 
0730 Meningitis / infection (including Malaria) 
0740 Cerebral emboli 
0800 METABOLIC 
0810 Maternal ketoacidosis 
0820 Thyroid crisis 
0900 DISSEMINATED INTRAVASCULAR COAGULATION 
0910 Disseminated intravascular coagulation 
1000 MULTI-ORGAN FAILURE 
1010 Multi-organ failure 
1100 IMMUNE SYSTEM FAILURE 
1110 HIV / AIDS 
1200 UNKNOWN 
1210 Home death 
1300 OTHER 
 
 
